Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Accent MicrocellNSE:ACCENTMIC +2.51%47 PEG Ratio is 0.64 as of Jul. 23, 2026, which is 12% above its 10-year median of 0.57. GuruFocus rates NSE:ACCENTMIC with a GF Score™ of 47/100. The stock has 6 warning signs investors should review. Among 351 Drug Manufacturers companies, Accent Microcell ranks better than 83.48% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Accent Microcell's PEG Ratio or its related term are showing as below:
NSE:ACCENTMIC'
s PEG Ratio Range Over the Past 10 Years
Min: 0.48 Med: 0.57 Max: 0.65
Current: 0.64
During the past 6 years, Accent Microcell's highest PEG Ratio was 0.65. The lowest was 0.48. And the median was 0.57.
NSE:ACCENTMIC's PEG Ratio is ranked better than 83.48% of 351
companies
in the Drug Manufacturers industry
Industry Median: 1.73
vs NSE:ACCENTMIC: 0.64
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Accent Microcell (NSE:ACCENTMIC) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Accent Microcell PEG Ratio Related Terms
Accent Microcell PEG Ratio Historical Data
* Premium members only.
The historical data trend for Accent Microcell's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Accent Microcell's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Accent Microcell PEG Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Accent Microcell's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Accent Microcell's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Accent Microcell (NSE:ACCENTMIC) has a PEG Ratio of 0.64 as of Jul. 23, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Accent Microcell and its competitors. This is 12% above median its historical median of 0.57. Over the past decade, Accent Microcell's PEG Ratio has ranged from 0.48 to 0.65. According to the industry distribution chart, Accent Microcell ranks #58 out of 351 companies in the Drug Manufacturers industry, placing it in the top 16.5%.
Is Accent Microcell's PEG Ratio too high?
Accent Microcell's current PEG Ratio of 0.64 is 12% above median its 10-year median of 0.57. Over the past 10 years, this metric has ranged from a low of 0.48 to a high of 0.65. The Drug Manufacturers industry median PEG Ratio is 1.73. Accent Microcell's value of 0.64 is 63% below this industry median. Based on the distribution chart, Accent Microcell ranks #58 out of 351 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Accent Microcell has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Accent Microcell's PEG Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Accent Microcell ranks #58 out of 351 companies for PEG Ratio. This places Accent Microcell in the top 17% of its industry — outperforming the majority of peers. The industry median PEG Ratio is 1.73. Accent Microcell's value of 0.64 is 63% below this benchmark. Historically, Accent Microcell's own PEG Ratio has ranged from 0.48 to 0.65 over the past decade. While the company's 10-year median is 0.57 vs. the industry median of 1.73, Accent Microcell has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Drug Manufacturers company?
The median PEG Ratio among Drug Manufacturers companies is 1.73, based on 351 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Accent Microcell's current PEG Ratio of 0.64 is 63% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Accent Microcell and its competitors. For the Drug Manufacturers industry, the median PEG Ratio is 1.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Accent Microcell's current PEG Ratio is 0.64, which is 12% above median its own 10-year median of 0.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accent Microcell stock overvalued right now?
Accent Microcell (NSE:ACCENTMIC) has a current PEG Ratio of 0.64. The current PEG Ratio is 0.64, which is 12% above median its 10-year median of 0.57 and 63% below the Drug Manufacturers industry median of 1.73. Accent Microcell's overall GF Score™ is 47/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Accent Microcell (NSE:ACCENTMIC), the current PEG Ratio is 0.64 as of Jul. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Accent Microcell Ltd is engaged in the manufacturing business of pharmaceutical excipients including products like Microcrystalline Cellulose which is a term for refined wood pulp and is used as a texturizer, an anti-caking agent, a fat substitute, an emulsifier, an extender, and a bulking agent in food production; Croscarmellose Sodium used as a super disintegrant in pharmaceutical formulations; Magnesium Stearate; Cellulose Powder, and others. Its business segments are segregated based on the location of its manufacturing facilities and include Dahej (SEZ Unit), Pirana, Unit III, and Inter Unit Sales. Geographically, a majority of the company's revenue is derived through the export of its products to various countries.
47GF Score
Get the complete analysis for NSE:ACCENTMIC
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ACCENTMIC has been successfully added to your 
